Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

REDUCE study clarifies effects of dutasteride in prostate cancer

April 30, 2010

Padeliporfin-mediated vascular targeted phototherapy promising in prostate cancer trial

April 30, 2010

Novel protein kinase inhibitors presented by Priaxon

April 30, 2010

AdventRx to resubmit ANX-530 NDA in fourth quarter of 2010

April 29, 2010

Phase II brostallicin/cisplatin trial in triple-negative breast cancer planned

April 29, 2010

Enrollment complete in OSI's phase III trial of erlotinib in NSCLC

April 29, 2010

In vivo safety and antitumor activity of ABI-013 disclosed

April 29, 2010

Pfizer details discovery and activity of dual PI3K/mTOR inhibitor PF-04691502

April 29, 2010

U.S. scientists claim new fused diimidazodiazepine agents

April 29, 2010

Concert Pharmaceuticals claims new inhibitors of VEGFR-1, -2 and -3

April 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...